The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(3'-nitro-4'-pyridyl)carboxamido]morphinan ID: ALA4530500
PubChem CID: 153536692
Max Phase: Preclinical
Molecular Formula: C26H28N4O6
Molecular Weight: 492.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5)c1ccncc1[N+](=O)[O-]
Standard InChI: InChI=1S/C26H28N4O6/c31-19-4-3-15-11-20-26(33)7-5-17(28-24(32)16-6-9-27-12-18(16)30(34)35)23-25(26,21(15)22(19)36-23)8-10-29(20)13-14-1-2-14/h3-4,6,9,12,14,17,20,23,31,33H,1-2,5,7-8,10-11,13H2,(H,28,32)/t17-,20-,23+,25+,26-/m1/s1
Standard InChI Key: XTJYQGUVQMWMBO-VWGUVZQXSA-N
Molfile:
RDKit 2D
38 44 0 0 0 0 0 0 0 0999 V2000
23.2860 -3.3706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6943 -2.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4611 -3.3706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6943 -4.0706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0611 -4.0831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8444 -4.5581 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3360 -1.9749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0486 -2.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2610 -1.1207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4485 -1.9374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8569 -2.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5109 -2.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5109 -4.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2320 -4.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8444 -1.6458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2236 -2.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9317 -3.3623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0985 -1.9249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8112 -3.3748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4984 -0.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6609 -0.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8112 -4.8121 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6860 -4.9872 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
24.0485 -1.5624 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
25.2299 -0.7787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2174 0.0662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9181 -4.7923 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7429 -4.7984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1500 -5.5160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1607 -4.0871 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7297 -6.2226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1361 -6.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9619 -6.9463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3796 -6.2300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9709 -5.5159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3846 -4.8021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2095 -4.8037 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9734 -4.0870 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 1 0
5 3 2 0
6 4 1 0
7 2 1 0
8 3 1 0
9 15 1 0
10 8 1 0
1 11 1 1
12 2 1 0
13 4 1 0
14 5 1 0
15 11 1 0
16 8 2 0
17 13 1 0
2 18 1 1
19 16 1 0
20 21 1 0
21 9 1 0
22 14 1 0
4 23 1 1
7 24 1 6
6 5 1 0
7 9 1 0
17 12 1 0
7 10 1 0
19 14 2 0
25 20 1 0
26 25 1 0
20 26 1 0
13 27 1 1
27 28 1 0
28 29 1 0
28 30 2 0
29 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 29 1 0
35 36 1 0
36 37 1 0
36 38 2 0
M CHG 2 36 1 37 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 492.53Molecular Weight (Monoisotopic): 492.2009AlogP: 2.06#Rotatable Bonds: 5Polar Surface Area: 138.06Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.08CX Basic pKa: 9.50CX LogP: 1.09CX LogD: -0.73Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.43Np Likeness Score: 0.41
References 1. Zheng Y, Obeng S, Wang H, Jali AM, Peddibhotla B, Williams DA, Zou C, Stevens DL, Dewey WL, Akbarali HI, Selley DE, Zhang Y.. (2019) Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands., 62 (2): [PMID:30608693 ] [10.1021/acs.jmedchem.8b01158 ]